Enhancement of 5-fluorouracil's anticancer activity by dipyridamole
- 1 January 1989
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 40 (3) , 349-371
- https://doi.org/10.1016/0163-7258(89)90084-3
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Expression of a novel high-affinity purine nucleobase transport function in mutant mammalian T lymphoblasts.Molecular and Cellular Biology, 1986
- Incomplete nucleoside transport deficiency with increased hypoxanthine transport capability in mutant T-lymphoblastoid cells.Molecular and Cellular Biology, 1986
- Nucleoside transport in Walker 256 rat carcinosarcoma and S49 mouse lymphoma cells. Differences in sensitivity to nitrobenzylthioinosine and thiol reagentsBiochemical Journal, 1985
- Characterization of mouse lymphoma cells with altered nucleoside transportJournal of Cellular Physiology, 1985
- Clinical pharmacokinetics of dipyridamoleThrombosis Research, 1983
- Nitrobenzylthioinosine-insensitive uridine transport in human lymphoblastoid and murine leukemia cellsBiochemical and Biophysical Research Communications, 1983
- An update on the biochemistry of 5-fluorouracilCancer Treatment Reviews, 1981
- DIPYRIDAMOLE: A POTENT STIMULATOR OF PROSTACYCLIN (PGI2) BIOSYNTHESISBritish Journal of Pharmacology, 1980
- Mode of action of dipyridamole on human plateletsThrombosis Research, 1979
- Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil responseBiochemical Pharmacology, 1978